Haemophilia

Introduction

  • Haemophilia is a hereditary bleeding disorder caused by deficiency of specific coagulation factors.

  • It results in prolonged or spontaneous bleeding due to defective blood clot formation.

  • The disorder primarily affects the intrinsic pathway of the coagulation cascade.

  • Haemophilia is most commonly inherited as an X-linked recessive condition.

  • Males are predominantly affected, while females usually act as carriers.

  • The two major forms are Haemophilia A (Factor VIII deficiency) and Haemophilia B (Factor IX deficiency).

  • Bleeding typically occurs into joints, muscles, and soft tissues, rather than superficial skin.

  • Hemarthrosis (joint bleeding) is the hallmark clinical feature.

  • Laboratory findings characteristically show prolonged aPTT with normal PT and platelet count.

  • With advances in factor replacement therapy and gene therapy, haemophilia is now a manageable chronic disorder.


Types of Haemophilia


Haemophilia is classified based on the specific coagulation factor deficiency. The major types are described below:

1. Haemophilia A

  • Also called Classic Haemophilia

  • Caused by Factor VIII deficiency

  • Accounts for 80–85% of cases

  • Inheritance: X-linked recessive

  • Common features:

    • Severe hemarthrosis

    • Muscle hematomas

    • Prolonged bleeding after surgery

  • Laboratory findings:

    • ↑ aPTT

    • Normal PT and bleeding time


2. Haemophilia B

  • Also known as Christmas Disease

  • Caused by Factor IX deficiency

  • Accounts for 15–20% of cases

  • Inheritance: X-linked recessive

  • Clinical presentation is indistinguishable from Haemophilia A

  • Diagnosed by Factor IX assay


3. Haemophilia C

  • Caused by Factor XI deficiency

  • Very rare

  • Inheritance: Autosomal recessive

  • Affects both males and females

  • Usually presents with:

    • Mild bleeding

    • Post-operative bleeding

  • Less common hemarthrosis


4. Acquired Haemophilia

  • Caused by autoantibodies against clotting factors (commonly Factor VIII)

  • Seen in:

    • Elderly individuals

    • Postpartum women

    • Autoimmune disorders

  • Not inherited

  • Presents with:

    • Sudden severe bleeding

    • No family history


Table

Type Deficient Factor Inheritance Frequency Severity
Haemophilia A Factor VIII X-linked Most common Mild–Severe
Haemophilia B Factor IX X-linked Common Mild–Severe
Haemophilia C Factor XI Autosomal Rare Mild
Acquired Factor VIII (inhibitors) Non-genetic Rare Severe

 


Genetic Basis


Haemophilia is primarily a genetic disorder of blood coagulation caused by mutations affecting genes responsible for clotting factor synthesis.

1. Mode of Inheritance

  • Haemophilia A and B follow an X-linked recessive inheritance

  • Predominantly affects males

  • Females are usually asymptomatic carriers


2. Gene Involvement

Type Gene Affected Chromosomal Location
Haemophilia A F8 gene X chromosome (Xq28)
Haemophilia B F9 gene X chromosome (Xq27)
  • These genes encode Factor VIII and Factor IX, respectively

  • Mutations lead to partial or complete absence of functional clotting factors


3. Types of Genetic Mutations

  • Point mutations

  • Insertions or deletions

  • Inversions (common in severe Haemophilia A)

  • Nonsense mutations leading to truncated proteins

Severity of haemophilia correlates with the type and extent of mutation.


4. Carrier State in Females

  • Females have two X chromosomes

  • One normal gene compensates for the defective one

  • Some carriers may show:

    • Mild bleeding

    • Reduced factor levels (due to lyonization / X-chromosome inactivation)


5. Inheritance Pattern

  • Carrier mother × normal father →

    • 50% sons affected

    • 50% daughters carriers

  • Affected father × normal mother →

    • All daughters carriers

    • Sons unaffected


6. De Novo Mutations

  • ~30% of cases occur due to new (sporadic) mutations

  • No previous family history

  • Important in genetic counseling


7. Genetic Basis of Haemophilia C

  • Caused by Factor XI gene mutations

  • Autosomal recessive inheritance

  • Affects both males and females

  • More common in certain ethnic populations


8. Clinical Significance

  • Helps in:

    • Prenatal diagnosis

    • Carrier detection

    • Genetic counseling

    • Personalized therapy and prognosis

 


Pathophysiology


Haemophilia is a coagulation disorder resulting from a defect in the intrinsic pathway of the coagulation cascade, leading to impaired fibrin clot formation and persistent bleeding.

1. Normal Coagulation 

  • Hemostasis occurs in three stages:

    1. Vascular constriction

    2. Platelet plug formation

    3. Coagulation cascade → fibrin clot

  • The intrinsic pathway involves Factors VIII, IX, XI, and XII

  • Factor VIII acts as a cofactor for Factor IXa in activating Factor X


2. Primary Defect in Haemophilia

Type Defective Factor Pathophysiological Effect
Haemophilia A Factor VIII Failure of intrinsic pathway
Haemophilia B Factor IX Inadequate Factor X activation
  • Reduced or absent factor activity leads to:

    • Poor conversion of prothrombin → thrombin

    • Reduced fibrinogen → fibrin

    • Weak, unstable clot formation


3. Effect on Hemostasis

  • Platelet plug forms normally

  • Fibrin stabilization is defective

  • Clot breaks down easily → recurrent bleeding


4. Site-Specific Bleeding

  • Joints (hemarthrosis):

    • Repeated bleeding → synovial inflammation

    • Cartilage destruction → haemophilic arthropathy

  • Muscles:

    • Hematoma formation

    • Compartment syndrome in severe cases

  • Soft tissues & CNS:

    • Life-threatening hemorrhage


5. Severity Correlation

  • Severity depends on residual clotting factor level

  • <1% activity → spontaneous bleeding

  • 1–5% → bleeding after minor trauma

  • 5% → bleeding after surgery/major trauma


6. Development of Inhibitors

  • Some patients develop alloantibodies against infused clotting factors

  • Neutralize therapeutic factor VIII or IX

  • Causes treatment resistance and severe bleeding


7. Acquired Haemophilia 

  • Autoantibodies against Factor VIII

  • Sudden onset bleeding

  • No family history

 


Clinical Features


1. General Bleeding Manifestations

  • Prolonged bleeding after:

    • Minor cuts

    • Tooth extraction

    • Surgery or trauma

  • Excessive bleeding after injections or vaccinations

  • Delayed bleeding (bleeding may restart hours after injury)


2. Hemarthrosis 

  • Most commonly affected joints:

    • Knee

    • Ankle

    • Elbow

  • Clinical signs:

    • Pain and swelling

    • Warmth and restricted movement

  • Recurrent episodes lead to:

    • Synovial inflammation

    • Cartilage destruction

    • Haemophilic arthropathy


3. Muscle Bleeding

  • Deep muscle hematomas (thigh, calf, iliopsoas)

  • Painful swelling and stiffness

  • Can cause:

    • Nerve compression

    • Compartment syndrome

    • Functional disability


4. Skin and Mucosal Bleeding

  • Easy bruising (ecchymosis)

  • Subcutaneous hematomas

  • Gum bleeding

  • Epistaxis (nosebleeds)


5. Internal and Life-Threatening Bleeding

  • Intracranial hemorrhage (most serious complication)

  • Gastrointestinal bleeding

  • Retroperitoneal hemorrhage

  • Hematuria (blood in urine)


6. Bleeding in Children

  • Excessive bleeding after circumcision

  • Large bruises during crawling or walking

  • Joint swelling in toddlers

  • Delayed diagnosis in mild cases


7. Severity-Based Clinical Presentation

Severity Factor Level Clinical Features
Severe < 1% Spontaneous bleeding, frequent hemarthrosis
Moderate 1–5% Bleeding after minor trauma
Mild > 5% Bleeding after surgery or major trauma

 


Laboratory Diagnosis


1. Screening Coagulation Tests

These tests help suspect haemophilia:

Test Finding in Haemophilia Explanation
Bleeding Time Normal Platelet function intact
Platelet Count Normal No platelet deficiency
Prothrombin Time (PT) Normal Extrinsic pathway normal
Activated Partial Thromboplastin Time (aPTT) Prolonged Intrinsic pathway defect

feature: Isolated prolongation of aPTT


2. Mixing Study 

  • Patient plasma mixed with normal plasma (1:1)

  • Correction of aPTT → Factor deficiency (Haemophilia A/B)

  • No correction → Presence of inhibitors (acquired haemophilia)


3. Specific Factor Assays

Disorder Test
Haemophilia A ↓ Factor VIII level
Haemophilia B ↓ Factor IX level
Haemophilia C ↓ Factor XI level
  • Determines type and severity

  • Factor activity expressed as percentage of normal


4. Severity Assessment

Factor Level Severity
< 1% Severe
1–5% Moderate
> 5% Mild

 


5. Inhibitor Assay

  • Performed in patients:

    • Not responding to therapy

    • With recurrent bleeding despite replacement

  • Bethesda assay used to quantify inhibitors


6. Additional Investigations

  • Complete blood count:

    • May show anemia due to blood loss

  • Liver function tests:

    • To rule out liver disease

  • Von Willebrand factor assay:

    • To exclude von Willebrand disease


7. Genetic Testing

  • Identification of F8 or F9 gene mutations

  • Used for:

    • Carrier detection

    • Prenatal diagnosis

    • Family screening


8. Diagnostic Flow 

  • Prolonged aPTT

  • Normal PT & bleeding time

  • Mixing study → correction

  • Factor assay → definitive diagnosis

 


MCQs


1. Haemophilia is best described as:

A. Platelet disorder
B. Vascular disorder
C. Coagulation factor deficiency
D. Autoimmune disorder

Answer: C


2. The most common type of haemophilia is:

A. Haemophilia B
B. Haemophilia C
C. Acquired haemophilia
D. Haemophilia A

Answer: D


3. Haemophilia A is due to deficiency of:

A. Factor VII
B. Factor VIII
C. Factor IX
D. Factor XI

Answer: B


4. Christmas disease refers to:

A. Haemophilia A
B. Haemophilia B
C. Haemophilia C
D. Von Willebrand disease

Answer: B


5. Haemophilia B is caused by deficiency of:

A. Factor VIII
B. Factor IX
C. Factor X
D. Factor XI

Answer: B


6. Mode of inheritance of Haemophilia A is:

A. Autosomal dominant
B. Autosomal recessive
C. X-linked recessive
D. X-linked dominant

Answer: C


7. Which sex is most commonly affected by haemophilia?

A. Females
B. Males
C. Both equally
D. Only newborns

Answer: B


8. Females with one defective haemophilia gene are usually:

A. Severely affected
B. Symptomatic
C. Carriers
D. Lethal

Answer: C


9. Haemophilia mainly affects which pathway of coagulation?

A. Extrinsic
B. Common
C. Intrinsic
D. Fibrinolytic

Answer: C


10. Hallmark clinical feature of haemophilia is:

A. Petechiae
B. Hemarthrosis
C. Purpura
D. Telangiectasia

Answer: B


11. Most commonly affected joint in haemophilia is:

A. Shoulder
B. Hip
C. Knee
D. Wrist

Answer: C


12. Bleeding time in haemophilia is usually:

A. Increased
B. Decreased
C. Normal
D. Variable

Answer: C


13. Platelet count in haemophilia is:

A. Decreased
B. Increased
C. Normal
D. Absent

Answer: C


14. Prothrombin time (PT) in haemophilia is:

A. Prolonged
B. Shortened
C. Normal
D. Absent

Answer: C


15. aPTT in haemophilia is:

A. Normal
B. Shortened
C. Prolonged
D. Variable

Answer: C


16. Test most sensitive for screening haemophilia is:

A. PT
B. Bleeding time
C. aPTT
D. Clot retraction

Answer: C


17. Confirmatory test for haemophilia A is:

A. PT
B. aPTT
C. Factor VIII assay
D. Platelet count

Answer: C


18. Severity of haemophilia depends on:

A. Age
B. Gender
C. Factor activity level
D. Platelet count

Answer: C


19. Severe haemophilia is defined as factor level:

A. <10%
B. <5%
C. <1%
D. <20%

Answer: C


20. Mixing study shows correction of aPTT indicates:

A. Inhibitor present
B. Platelet defect
C. Factor deficiency
D. Liver disease

Answer: C


21. Failure of aPTT correction in mixing study suggests:

A. Vitamin K deficiency
B. Liver disease
C. Presence of inhibitors
D. Mild haemophilia

Answer: C


22. Test used to detect inhibitors is:

A. ELISA
B. Coombs test
C. Bethesda assay
D. Western blot

Answer: C


23. Haemophilia C is caused by deficiency of:

A. Factor VIII
B. Factor IX
C. Factor XI
D. Factor XII

Answer: C


24. Haemophilia C inheritance pattern is:

A. X-linked recessive
B. Autosomal recessive
C. Autosomal dominant
D. Mitochondrial

Answer: B


25. Haemophilia C affects:

A. Only males
B. Only females
C. Both sexes
D. Only children

Answer: C


26. Most serious complication of haemophilia is:

A. Anemia
B. Hemarthrosis
C. Intracranial hemorrhage
D. Muscle bleeding

Answer: C


27. Repeated joint bleeding leads to:

A. Osteoporosis
B. Rheumatoid arthritis
C. Haemophilic arthropathy
D. Septic arthritis

Answer: C


28. Preferred treatment for haemophilia is:

A. Blood transfusion
B. Vitamin K
C. Factor replacement therapy
D. Steroids

Answer: C


29. Drug useful in mild Haemophilia A is:

A. Warfarin
B. Aspirin
C. Desmopressin
D. Heparin

Answer: C


30. Drug contraindicated in haemophilia is:

A. Paracetamol
B. Aspirin
C. Tranexamic acid
D. Factor VIII

Answer: B


31. Gene therapy in haemophilia aims to:

A. Destroy platelets
B. Suppress immunity
C. Correct defective gene
D. Increase vitamin K

Answer: C


32. Acquired haemophilia is caused by:

A. Genetic mutation
B. Platelet defect
C. Autoantibodies against factor VIII
D. Vitamin deficiency

Answer: C


33. Acquired haemophilia commonly occurs in:

A. Children
B. Neonates
C. Elderly
D. Teenagers

Answer: C


34. Hematuria in haemophilia indicates:

A. Platelet defect
B. Renal bleeding
C. Liver disease
D. Infection

Answer: B


35. Muscle hematomas may cause:

A. Hypercalcemia
B. Nerve compression
C. Hypotension only
D. Rash

Answer: B


36. Best method to prevent haemophilia complications is:

A. Surgery
B. Genetic counseling
C. Chemotherapy
D. Radiation

Answer: B


37. Prenatal diagnosis of haemophilia is done by:

A. CBC
B. Ultrasound
C. Genetic testing
D. PT test

Answer: C


38. Which factor is a cofactor for Factor IXa?

A. Factor V
B. Factor VIII
C. Factor XI
D. Factor XII

Answer: B


39. Delayed bleeding after trauma is characteristic of:

A. Platelet disorders
B. Vascular disorders
C. Haemophilia
D. DIC

Answer: C


40. In haemophilia, platelet plug formation is:

A. Absent
B. Defective
C. Normal
D. Increased

Answer: C


41. Main reason for prolonged bleeding in haemophilia is:

A. Platelet deficiency
B. Weak fibrin clot
C. Vasodilation
D. Infection

Answer: B


42. Which factor level correlates with severity?

A. Platelet count
B. PT value
C. Factor VIII/IX activity
D. Bleeding time

Answer: C


43. Most common presenting age for severe haemophilia is:

A. Old age
B. Adolescence
C. Infancy
D. Adulthood

Answer: C


44. Preferred physical activity in haemophilia patients is:

A. Boxing
B. Football
C. Swimming
D. Weight lifting

Answer: C


45. Major cause of joint deformity in haemophilia is:

A. Infection
B. Recurrent bleeding
C. Vitamin deficiency
D. Osteoporosis

Answer: B


46. Which lab test differentiates haemophilia from VWD?

A. PT
B. aPTT
C. Bleeding time
D. Platelet count

Answer: C


47. In haemophilia, fibrin formation is:

A. Excessive
B. Normal
C. Reduced
D. Accelerated

Answer: C


48. Gene affected in Haemophilia A is located on:

A. Chromosome 1
B. Chromosome 7
C. X chromosome
D. Y chromosome

Answer: C


49. Most common cause of death in untreated haemophilia is:

A. Anemia
B. Infection
C. Intracranial bleeding
D. Renal failure

Answer: C


50. Best long-term management strategy is:

A. Symptomatic treatment
B. Prophylactic factor replacement
C. Blood transfusion only
D. Surgery

Answer: B